/Companies

Abata Therapeutics

Cambridge, US · 3 known investors

Find your way into Abata Therapeutics

Investors · 3

Reported raises · per SEC filings

Form D private placements

$60.3M disclosed across 2 rounds · 2021–2023

▶$15.3MraisedDec 2023 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • SAMANTHA SINGERExecutive Officer, Director
  • LEONARD DRAGONEExecutive Officer
  • VALERIE ODEGARDDirector
  • STEPHEN SOFENExecutive Officer
  • SANDY LAZZARIExecutive Officer
  • SHELLEY CHUDirector
  • NAGESH MAHANTHAPPADirector
  • JOHN TRZUPEKExecutive Officer
  • ABBIE CELNIKERDirector
  • MITCH FINERDirector
  • DAVID KAUFMANDirector
  • LORENCE KIMDirector
  • ELLEN CAHIR-MCFARLANDExecutive Officer
Amount sold
$15.3M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45MraisedJun 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • SAMANTHA SINGERExecutive Officer, Director
  • ABBIE CELNIKERDirector
  • MITCH FINERDirector
  • NAGESH MAHANTHAPPADirector
  • LORENCE KIMDirector
  • SANDY LAZZARIExecutive Officer
  • SHELLEY CHUDirector
  • STEPHEN SOFENExecutive Officer
  • VALERIE ODEGARDDirector
  • JOHN TRZUPEKExecutive Officer
Offering amount
$95M
Amount sold
$45M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Abata Therapeutics's investors?
Abata Therapeutics's investors include Lightspeed Venture Partners, Ascenta Capital, Third Rock Ventures.
How much funding has Abata Therapeutics raised?
Abata Therapeutics has disclosed $60.3M raised across 2 rounds.
Where is Abata Therapeutics headquartered?
Abata Therapeutics is headquartered in Cambridge, US.